Skip to main content
SpringerLink
Log in

Resistenz gegen endokrine Therapie bei Mammakarzinomen

Sind veränderte Biomarker schuld?

  • journal club
  • Published:
Info Onkologie Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Originalie

  • Arnedos M et al. Biomarker changes associated with the development of resistance to aromatase inhibitors (AIs) in estrogen receptor-positive breast cancer. Ann Oncol. 2014;25(3):605–10.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hamburg, Deutschland

    Ulrich R. Kleeberg (Hämatologisch-onkologische Praxis Altona, Tagesklinik Struensee-Haus)

Authors
  1. Ulrich R. Kleeberg
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Ulrich R. Kleeberg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kleeberg, U.R. Resistenz gegen endokrine Therapie bei Mammakarzinomen. Info Onkol. 17, 25–26 (2014). https://doi.org/10.1007/s15004-014-0876-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15004-014-0876-0

Schlüsselwörter

Search

Navigation